These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 17383239)

  • 21. Combination drug therapy for the prevention of exercise-induced bronchoconstriction in children.
    de Benedictis FM; Tuteri G; Pazzelli P; Solinas LF; Niccoli A; Parente C
    Ann Allergy Asthma Immunol; 1998 Apr; 80(4):352-6. PubMed ID: 9564987
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety of salmeterol in the maintenance treatment of asthma.
    Nathan RA; Seltzer JM; Kemp JP; Chervinsky P; Alexander WJ; Liddle R; Mills R
    Ann Allergy Asthma Immunol; 1995 Sep; 75(3):243-8. PubMed ID: 7552926
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [symbol: see text] Seretide and [symbol: see text] Symbicort in asthma management.
    Drug Ther Bull; 2002 Aug; 40(8):62-4. PubMed ID: 12216339
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An inhaled glucocorticoid does not prevent tolerance to the bronchoprotective effect of a long-acting inhaled beta 2-agonist.
    Yates DH; Kharitonov SA; Barnes PJ
    Am J Respir Crit Care Med; 1996 Dec; 154(6 Pt 1):1603-7. PubMed ID: 8970342
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dual components of optimal asthma therapy: scientific and clinical rationale for the use of long-acting beta-agonists with inhaled corticosteroids.
    Naedele-Risha R; Dorinsky P; Craig TJ
    J Am Osteopath Assoc; 2001 Sep; 101(9):526-33. PubMed ID: 11575039
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Part IV: Genetic variations in beta2-adrenergic receptors: long-acting and short-acting beta2-agonists and therapeutic response.
    Peters S
    Curr Med Res Opin; 2007 Sep; 23 Suppl 3():S29-36. PubMed ID: 17925066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adrenergic beta(2)-receptor genotype predisposes to exacerbations in steroid-treated asthmatic patients taking frequent albuterol or salmeterol.
    Basu K; Palmer CN; Tavendale R; Lipworth BJ; Mukhopadhyay S
    J Allergy Clin Immunol; 2009 Dec; 124(6):1188-94.e3. PubMed ID: 19800676
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potential masking effects of salmeterol on airway inflammation in asthma.
    Mcivor RA; Pizzichini E; Turner MO; Hussack P; Hargreave FE; Sears MR
    Am J Respir Crit Care Med; 1998 Sep; 158(3):924-30. PubMed ID: 9731027
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Should combination therapy with inhaled corticosteroids and long-acting beta2-agonists be prescribed as initial maintenance treatment for asthma?
    Lemière C; Becker A; Boulet LP; Bowie D; Cartier A; Cockroft D; Cowie R; Ernst P; Fitzgerald M; Sears M; Spier S
    CMAJ; 2002 Oct; 167(9):1008-9. PubMed ID: 12403741
    [No Abstract]   [Full Text] [Related]  

  • 30. The effect of polymorphisms of the beta(2)-adrenergic receptor on the response to regular use of albuterol in asthma.
    Israel E; Drazen JM; Liggett SB; Boushey HA; Cherniack RM; Chinchilli VM; Cooper DM; Fahy JV; Fish JE; Ford JG; Kraft M; Kunselman S; Lazarus SC; Lemanske RF; Martin RJ; McLean DE; Peters SP; Silverman EK; Sorkness CA; Szefler SJ; Weiss ST; Yandava CN
    Am J Respir Crit Care Med; 2000 Jul; 162(1):75-80. PubMed ID: 10903223
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pretreatment with albuterol versus montelukast for exercise-induced bronchospasm in children.
    Raissy HH; Harkins M; Kelly F; Kelly HW
    Pharmacotherapy; 2008 Mar; 28(3):287-94. PubMed ID: 18294107
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Salmeterol response is not affected by beta2-adrenergic receptor genotype in subjects with persistent asthma.
    Bleecker ER; Yancey SW; Baitinger LA; Edwards LD; Klotsman M; Anderson WH; Dorinsky PM
    J Allergy Clin Immunol; 2006 Oct; 118(4):809-16. PubMed ID: 17030231
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optimal and efficient crossover designs under different assumptions about the carryover effects.
    Hedayat AS; Stufken J
    J Biopharm Stat; 2003 Aug; 13(3):519-28. PubMed ID: 12921398
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-acting beta 2-agonist salmeterol compared with albuterol in maintenance asthma therapy.
    Pearlman DS
    Ann Allergy Asthma Immunol; 1995 Aug; 75(2):180-4. PubMed ID: 7648385
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of inhaled corticosteroids: an update.
    Kelly HW
    Ann Pharmacother; 2009 Mar; 43(3):519-27. PubMed ID: 19261959
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Case-crossover design in air pollution epidemiology.
    Jaakkola JJ
    Eur Respir J Suppl; 2003 May; 40():81s-85s. PubMed ID: 12762580
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Crossing controls to treatment in repeated-measures trials.
    Jarjoura D
    Control Clin Trials; 2003 Jun; 24(3):306-23. PubMed ID: 12757996
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of two-treatment, two-period crossover trials in emergency medicine.
    Reed JF
    Ann Emerg Med; 2004 Jan; 43(1):54-8. PubMed ID: 14707941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Underestimation of treatment effect in crossover trials.
    Cleophas TJ
    Angiology; 1990 Sep; 41(9 Pt 1):673-80. PubMed ID: 2221469
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Meta-analysis combining parallel and crossover trials using generalised estimating equation method.
    Curtin F
    Res Synth Methods; 2017 Sep; 8(3):312-320. PubMed ID: 28585280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.